Theresa Greco - 01 Nov 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Chief Commercial Officer
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 01 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2023, 10:49:11 UTC
Previous filing: 30 Oct 2023
Next filing: 05 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPRX	Common Stock	Award	$0	+18,519	+100%	$0.000000	37,038	01 Nov 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Stock Option	Award	$0	+35,758		$0.000000	35,758	01 Nov 2023	Common Stock	35,758	$8.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on November 1, 2024, which is the first anniversary of the date of grant.
F2	The stock option vests in three equal annual installments beginning November 1, 2024, the first anniversary of the grant date.